Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Jeremy Hutcher’s practice enables and accelerates digital transformation. He has led a number of the most innovative and complex commercial transactions involving the use of software, technology, intellectual property and data to transform an industry.  Mr. Hutcher works with clients on a variety of cutting-edge product development and commercialization matters, collaborations and strategic alliances, including joint venture, distribution, information technology procurement and outsourcing arrangements. His digital transformation deal experience is broad and deep.

  • Advising AstraZeneca on its global digital health partnership with BrightInsight for the development of digital health products and services (including Software as a Medical Device products).
  • Advising AstraZeneca regarding the development, clinical evaluation and commercial launch of the AMAZE Health Management platform.
  • Advising AstraZeneca regarding a collaboration and services arrangement with a technology company to develop and support a combination product comprised of a drug and a digital health tool.
  • Advising Astellas Pharma Inc. regarding its collaboration and license agreement with Welldoc to develop and commercialize digital health solutions for patients with diabetes and in other therapeutic areas.
  • Advising a global pharmaceutical company regarding its clinical research arrangements involving the study of digital health products for the treatment of ALS.
  • Advising Ascension and AMITA Health regarding its arrangements with R1 RCM for the provision of revenue cycle services across its acute care-based facilities and physician groups.
  • Advising Monumental Sports & Entertainment in connection with its partnership with William Hill to create the first sportsbook at a U.S. professional sports venue.
  • Advising the WWE in its deals with Endeavor Streaming and Massive Interactive to redesign and relaunch WWE Network.
  • Advising the National Hockey League on its partnership with GameOn regarding the launch and operation of the AI-powered NHL Chatbot. 
  • Advising the LA Clippers on its partnership with Second Spectrum regarding the development and operation of an AI-enhanced, augmented reality video streaming product.  
  • Advising Riot Games on its long-term commercialization partnership with BAMTech.
  • Advising the National Basketball Association on its virtual reality agreement with NextVR.
  • Advising the National Basketball Association on its global merchandising and marketing partnership with Nike.
  • Advising Turner Sports on the extension of its “March Madness” rights with the NCAA.
  • Advising American Airlines on the licensing of the “TWA” brand in connection with the TWA Hotel located at JFK Airport.
  • Advising the National Football League on its next generation data collaboration with Sportradar, a European sports data company.
  • Advising the National Hockey League on its digital rights partnership with Major League Baseball Advanced Media.
  • Advising sports teams in connection with the negotiation of their local media rights agreements.
  • Advising the National Geographic Society in connection with its entry into a joint venture with 21st Century Fox covering cable television, technology and media assets.
  • Advising Piramal Enterprises in the acquisition of anesthesia and pain management injectable products from Janssen.
  • Advising Apple Leisure Group in a series of information technology transactions.